PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

SWISS MEDICAL WEEKLY is a leading peer-reviewed journal published by the SMW supporting association, available in both print and digital formats under open access since 2001. With an ISSN of 1424-7860 and E-ISSN 1424-3997, this journal has established itself as a crucial platform for disseminating innovative research and clinical advancements in the field of Medicine. Based in Basel, Switzerland, the journal boasts an impressive Scopus ranking of #101 among 636 in the General Medicine category, placing it in the 84th percentile and categorized in the Q3 Quartile of journals for 2023. Covering a wide range of topics relevant to contemporary medical practice and research, the SWISS MEDICAL WEEKLY serves not only as a valuable resource for healthcare professionals but also as a pivotal publication for academic researchers and students alike. By providing open access to high-quality research, it encourages knowledge sharing and fosters collaboration across borders, making significant contributions to the global medical community.

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

SOUTHERN ECONOMIC JOURNAL, published by Wiley, serves as a premier platform for scholarly research in the fields of economics and econometrics. With an impressive track record spanning from 1976 to 2024, this journal is esteemed for its contributions to economic theory, empirical research, and policy discussions, making it a critical resource for researchers, professionals, and students alike. Holding a commendable Q2 ranking in its category for 2023, it highlights its influence and standing in the field, ranking #291 out of 716 in Scopus within Economics and Econometrics, placing it in the 59th percentile. While it operates on a subscription model, the journal ensures broad accessibility to its content, fostering academic collaboration and knowledge dissemination. For those striving for a deeper understanding of contemporary economic issues, the SOUTHERN ECONOMIC JOURNAL is a vital resource that enriches the discourse in the economic community.

Health Services Research and Managerial Epidemiology is an esteemed peer-reviewed journal published by SAGE Publications Inc, dedicated to advancing the fields of health services research and epidemiology. With the ISSN 2333-3928, this Open Access journal, available since 2014, aims to foster a deeper understanding of the managerial aspects of epidemiology and its implications for health service delivery. By offering insights into critical healthcare policies and practices, the journal serves as an important resource for researchers, practitioners, and students alike. As of 2023, it is classified in the Q3 quartile for both Epidemiology and Health Policy, ranking within the 31st and 30th percentiles, respectively, in Scopus rankings. The journal’s scope encompasses a wide variety of topics, ranging from health management practices to innovative research methodologies, making it a key platform for disseminating influential work that shapes health policy and public health strategies. Operating out of the United States, at 2455 Teller Rd, Thousand Oaks, CA 91320, it continues to push the boundaries of knowledge in an increasingly vital area of study.

MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES is a prestigious journal published by the OFFICE INTERNATIONAL DES EPIZOOTIES based in France, known globally for its commitment to advancing knowledge in the fields of Animal Science and Zoology as well as Medicine. With its ISSN 0253-1933 and E-ISSN 1608-0637, this journal has been a vital resource for researchers and practitioners since its establishment in 1990. Currently ranked in the Q3 quartile across both the Animal Science and Medicine categories in 2023, it reflects a growing impact in the veterinary community, holding commendable ranks in the veterinary general and miscellaneous categories. Although it does not offer open access options, its comprehensive articles are crucial for informing best practices, public health policies, and advancing research in veterinary medicine. With an emphasis on innovative approaches and evidence-based studies, the journal serves as a significant platform for networking and collaboration among scholars, professionals, and students dedicated to improving animal health and welfare worldwide.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.